Facing Pricing Pressure And Generic Erosion, Simcere Shifts To Innovative Products For Future Growth: China Earnings Roundup (Part I)
By
Jialing Dai / Email the Author / PharmAsia News Nov. 22, 2011 6:00 PM GMT
China / Word Count: 1302 / Article # 28111122007
Executive Summary
China’s healthcare industry saw slower growth in the third quarter. In a recurring feature, PharmAsia News combs through earnings reports to bring you highlights of China’s leading pharma companies and how their efforts affect different sectors of the industry.
$85.00
Buy Now
For $85.00, purchase this 1302-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.